The Washington State Senate Health Care Committee held a public hearing today on Senate Bill 5379, a measure to add post traumatic stress disorder (PTSD) as a qualifying condition for those wanting to become medical cannabis patients.
At the public hearing, only Seth Dawson of the Washington State Psychiatric Association and the Washington Association of Substance Abuse Prevention spoke in opposition, with 14 people speaking in favor.
Research has continually shown that cannabis can be useful for those with PTSD. For example, in November, 2013, a government-funded study using human trials found that “the cannabinoid system may serve as a promising target for innovative intervention strategies (e.g. pharmacological enhancement of exposure-based therapy) in PTSD and other fear learning-related disorders.”
A study published the next year in June in the journal Neuropsychopharmacology came to a similar conclusion, finding that cannabinoids may treat PTSD.
A study published in December in the journal Psychoneuroendocrinology found that cannabis may provide a treatment option for those suffering from post traumatic stress disorder (PTSD)-induced nightmares.
According to the National Institute of Health, PTSD affects around 7.7 million people.
Senate Bill 5379 was filed by Senator Steve Hobbs, an active member of the Army National Guard, and is cosponsored by a bipartisan group of seven senators. If approved into law, Washington will join Michigan, California, Connecticut, Delaware, Maine, Massachusetts, New Mexico, Arizona and Oregon as states that have PTSD as a qualifying medical cannabis condition.